Rampart Bioscience Alternatives & Competitors
12 companies similar to Rampart Bioscience — Leading a new era of effective, safe and accessible gene medicines.
Companies similar to Rampart Bioscience
ReNAgade Therapeutics
RNA Without Limits
Cambridge, United States
Basilard BioTech, Inc.
Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies
United States
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
BreezeBio
Genetic Medicine Delivered
Brisbane, United States
Rival Readout
Competing with Rampart Bioscience? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ring Therapeutics
Founded by Flagship Pioneering, Ring is pioneering a new class of targeted medicines that...
Cambridge, United States
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
CAMP4 Therapeutics
Advancing a pipeline of ASO-based, RNA-targeting therapeutics with the aim to restore heal...
Cambridge, United States
Providence Therapeutics
Where Hope and Science Intersect
Calgary, Canada
Bloomsbury Genetic Therapies
Dedicated to delivering the promise of gene therapy
London, United Kingdom
Applied Molecular Transport
We are committed to developing transformational biologic medicines to serve patients with...
South San Francisco, Unit...
Poseida Therapeutics, Inc.
A Member of the Roche Group
San Diego, United States
ViaNautis
Targeted Nanomedicines
Cambridge, United Kingdom
About Rampart Bioscience
Rampart Bioscience, founded in 2019, is pioneering advancements in the Biopharma and Biotechnology industries. Based in the United States, the company aims to lead a new era of effective, safe, and accessible gene medicines, targeting patients with genetically driven diseases. Its innovative approach integrates capabil...
Development of Novel DNA-Based Medicines, Research in Gene Delivery and Protein Sciences, Non-Viral DNA Delivery Systems
Patients with Genetically Driven Diseases, Healthcare Providers Seeking Advanced Therapies
Gene Medicines, Genetically Driven Diseases, Gene Delivery, Protein Sciences, Clinical Translation, Non-viral DNA Delivery, Therapeutic Optimization, Potency Enhancement, Durability Of Treatment, Redosability, Safety In Gene Therapies, Proprietary Development Platforms, Non-viral Therapeutics, Biotechnology Innovation, Disease Treatment Reshaping
B2B, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Rampart Bioscience: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Rampart Bioscience on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
